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Class II antigens of the major histocompatibility complex (MHC) are essential elements for the cellular interactions involved in the immune response (see ref. 1 for a review). Constitutive expression ofclass II MHC antigens is restricted principally to B cells (2) . However, certain cell types, such as macrophages or epithelial cells (3) , can express class II MHC antigens after induction with interferon y (IFN-y). This phenomenon is an important step in the presentation of foreign antigens to helper T cells and in the activation of the immune response (reviewed in ref. 4) .
Besides its role in class II MHC antigen induction, IFN-y possesses numerous biological properties including antiviral and antiproliferative activities. It also has the ability to stimulate the transcription of several genes, including the genes coding for the MHC class I antigens (5, 6) . IFN-y acts by binding to a cell surface receptor (7) . The human IFN-y receptor gene has been isolated (8) and localized to human chromosome 6 at the locus 6q23-q24 (9) . However, humanmouse somatic cell hybrids containing human chromosome 6 express the human receptor and bind human IFN-y (Hu-IFN-y) but do not show a biological response. In fact, stimulation of the expression of class I MHC antigen by Hu-IFN-y requires additional species-specific factor(s) encoded by human chromosome 21 (10) . These requirements are different for hematopoietic cells, in which chromosome 21 is not necessary (11) .
On the other hand, the mechanism leading to the induction of class II MHC antigen expression by IFN-'y is still unclear. The -180 to + 10 region of class II gene promoters is required for transcriptional induction by IFN-y (12) . However, the various DNA-binding proteins known to interact with class II gene promoters are not affected by IFN-y treatment (13) . Furthermore, inhibitor studies have led to controversial results regarding the requirement for protein synthesis (14, 15) , for posttranscriptional regulation (16, 17) , or for the involvement of protein kinase C (18, 19) in class II MHC antigen induction by IFN-y.
We have therefore attempted to identify factors involved in the induction of class II MHC antigens by IFN-y, using a somatic cell hybrid approach. We tTo whom reprint requests should be addressed.
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our laboratory by transformation with the Epstein-Barr virus. JM is a human T-cell line. The BLS-1 and BLS-2 cell lines (kindly provided by J. Lee, Sloan-Kettering Institute, New York) were derived from bare-lymphocyte syndrome, class II antigen-deficient B cells (20) . All these human cells were cultured in RPMI 1640 medium supplemented with 10% fetal bovine serum. The human fibroblast cell line 2417-85 (21) was cultivated in DMEM supplemented with 10% fetal bovine serum.
Somatic Cell Hybrids. Hybrids were obtained by fusing (21) human cell lines with the hypoxanthine phosphoribosyltransferase-deficient mouse renal adenocarcinoma cell line RAG. The hybrids behaved as adherent cells and were morphologically similar to RAG cells. The karyotype was determined by the G-banding technique adapted from Seabright (22) . The presence ofhuman chromosome 6 was repeatedly checked by indirect immunofluorescence with antibodies directed against the human class I MHC antigens. The presence of human chromosome 21 was also verified by antiviral protection (11) using Hu-IFN-f3, as this chromosome encodes the Hu-IFN-a//3 receptor (23).
Monoclonal Antibodies. Human class I histocompatibility antigens were detected with monoclonal antibody W6/32 (24) . Mouse class I histocompatibility antigens were detected with monoclonal antibody 20.8.4 (25) . Human HLA-DR antigens were detected with monoclonal antibody L112 (26) . Monoclonal antibodies MKD6 and 14.4.4 were used to detect mouse I-Ad and I-Ed class II histocompatibility antigens, respectively (27, 28) . The Hu-IFN-y receptor was detected with the monoclonal antibody A6C5, which was a kind donation of G. Merlin (29) .
Immunofluorescence Assays. Subconfluent cell cultures were treated with Hu-IFN-y (500 units/ml) or Mu-IFN-y (250 units/ml) for 72 hr. Indirect immunofluorescence assays were done as described (11) . The analysis was performed using a FACScan (Becton Dickinson) with a Consort 30 program.
Northern Blot Analysis. Total RNA was isolated from subconfluent cultures with the guanidinium thiocyanate method (30) . RNA samples (10 ,ug per lane except for the blot prepared for DRa, where 20 ,ug of RNA was used) were loaded on agarose gels containing 2.2 M formaldehyde. The probes were labeled using the Multiprime labeling kit from Amersham.
Probes. The HLA-DPB, -DQB, and -DRa probes were kindly provided by C. Auffray (Institut d'Embryologie, Nogent sur Hame, France). The DPB and DQ13 probes contain the 3' untranslated region of the cDNAs of each isotype, and the DRa probe contains the cDNA encoding part of the al and a2 domains of DRa. All three probes are highly speciesspecific and isotype-specific (31) . The Ad probe is a 0.775-kilobase-pair Pst I fragment of the cDNA encoding the Aa antigen, corresponding to the a1, a2, and transmembrane domains (32) . Plasmid pHLA1 carries a cDNA insert that hybridizes to HLA-A, -B, and -C mRNAs (33) G418 (Geneticin, GIBCO) at 1 mg/ml.
RESULTS
Hybrids. Upon treatment with Mu-IFN-y, the murine RAG cells display an increase of class I MHC (H-2) antigen expression ( Fig. 1) and are protected against viral infection (data not shown). However, treatment with Mu-IFN-y does not induce the expression of either I-A or I-E murine class II MHC antigens as assessed by immunofluorescence techniques and by Northern blot analysis ( Fig. 1 and 2 Table 2 .
IFN-y receptor encoded by human chromosome 6, (ii) the analysis of the human chromosomal content of species-specific product(s) encoded by human chromosome and their I-A antigen inducibility shows a clear 21, and (iii) the non-species-specific product(s) of human oetween the inducible phenotype and the preschromosome 16. Similar requirements were also found for the gle chromosome, human chromosome 16. Sim-R.2417, R.LM, R.JM, and R.BLS hybrids ( t-, Not observed; 1, present in <25% of the mitoses analyzed; 2, 25-50%o; 3, 50-75%; 4, >75%.
R.GES.2.7 does not display any induction of I-A, DR, DQ,
or DP mRNAs by either species of IFN-'y. This result (17) . However, cell-surface expression of both I-A and I-E antigens, which are the murine equivalents of DQ and DR, respectively (39), was strongly induced by Mu-and Hu-IFN-y. In addition, different basal as well as induced levels of expression were observed between human and murine class II genes (Fig. 2) . The tissue of origin and hence the dissimilar state of expression of these genes could be related to such an observation.
Hybrids originating from the T-cell line (JM), although inducible by IFN-y for the expression of I-A antigens, were not inducible for the expression of cell-surface HLA-DR antigens. Similar results were observed with the BLS hybrids originating from class II-negative mutant B-cell lines. However, the fusion of BLS cell lines and a human B-cell line whose HLA-DR gene was deleted gave rise to heterokaryons that expressed class II MHC antigens (20) . In contrast, BLS-HeLa (human adenocarcinoma) heterokaryons did not exhibit any constitutive class II expression (20) . Taken as a whole, these results suggest that the absence of HLA-DR expression in the R.BLS hybrids could be related to the lack of a tissue-specific factor.
Although we have demonstrated the involvement of a non-species-specific factor encoded by human chromosome 16 in the induction of class II MHC antigens by IFN-y 
